Inova Schar Cancer Institute, Inova Health System, Fairfax, Virginia, USA.
Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Int J Cancer. 2024 Dec 15;155(12):2159-2168. doi: 10.1002/ijc.35095. Epub 2024 Sep 2.
The carcinogenicity of benzene was reevaluated by the International Agency for Research on Cancer in 2017, with the Working Group reaffirming positive yet inconclusive associations with non-Hodgkin lymphoma (NHL). To extend our previous observation of a significant exposure-response for cumulative occupational benzene exposure and NHL risk among Chinese women in a population-based cohort in Shanghai, we extended follow-up of this cohort and pooled the data with a similarly designed population-based cohort of men in Shanghai. Cumulative exposure estimates were derived for 134,449 participants in the pooled analysis by combining ordinal job-exposure matrix intensity ratings with quantitative benzene measurements from an inspection database of Shanghai factories. Associations between benzene exposure metrics and NHL (n = 363 cases including multiple myeloma [MM]) were assessed using Cox proportional hazard models. Ever occupational exposure to benzene in the pooled population was associated with NHL risk (HR = 1.5, 95% CI = 1.2-2.0), and exposure-response relationships were observed for increasing duration (p = .003) and cumulative exposure (p = .003). Associations with ever exposure, duration, and cumulative exposure were similar for NHL with and without MM in the case definition, including lifetime cumulative exposures in the highest quartile (HR = 1.6, 95% CI = 1.1-2.4 with MM included; HR = 1.7, 95% CI = 1.1-2.7 with MM excluded). An elevated risk of the chronic lymphocytic leukemia subtype was suggested in the pooled analyses (HR for ever vs. never exposure = 2.3, 95% CI = 0.9-5.6). These observations provide additional support for a plausible association between occupational benzene exposure and risk of NHL.
国际癌症研究机构(IARC)在 2017 年重新评估了苯的致癌性,工作组再次确认苯与非霍奇金淋巴瘤(NHL)之间存在阳性但尚无定论的关联。为了扩展我们之前在中国上海基于人群的队列中观察到的职业苯暴露与 NHL 风险之间存在显著累积暴露反应的研究结果,我们对该队列进行了随访,并将数据与上海另一项具有相似设计的基于人群的男性队列进行了合并。在合并分析中,通过将有序的职业暴露矩阵强度评分与上海工厂检查数据库中的定量苯测量值相结合,为 134449 名参与者计算了累积暴露估计值。使用 Cox 比例风险模型评估了苯暴露指标与 NHL(包括多发性骨髓瘤[MM]在内的 363 例病例)之间的关联。在合并人群中,苯的职业暴露与 NHL 风险相关(HR=1.5,95%CI=1.2-2.0),并且随着暴露时间(p=0.003)和累积暴露(p=0.003)的增加,观察到了暴露反应关系。在病例定义中,无论是否包含 MM,苯的终生累积暴露量最高四分位数(包括 MM 时 HR=1.6,95%CI=1.1-2.4;不包括 MM 时 HR=1.7,95%CI=1.1-2.7)与 NHL 的终生累积暴露量最高四分位数与 NHL 风险之间存在相似的关联。在合并分析中,提示慢性淋巴细胞白血病亚型的风险增加(与从不暴露相比,HR=2.3,95%CI=0.9-5.6)。这些观察结果为职业苯暴露与 NHL 风险之间存在可能的关联提供了额外的支持。